Penile Cancer: Metastatic Verification and Inguinal Nodal Management

Authored by Open Medicine, published on 2026-10-30 19:53:18.0

The algorithm is broadly consistent with contemporary penile cancer management by separating distant metastatic disease, biopsy-confirmed regional disease, and cN0 risk-adapted nodal management. It appropriately prioritizes ultrasound-guided assessment, pathological confirmation, dynamic sentinel lymph node biopsy at experienced centers, and surveillance for selected low-risk or pathologically node-negative patients. Alignment is mixed because the title inaccurately frames a largely cN0/regional-staging algorithm as metastatic disease, and modified ILND with frozen section is a less strongly supported fallback than DSNB or more comprehensive surgical staging.

  1. Verify Newly Reported Metastatic Status
    • Classify Current Disease State
      • Does the M1 Finding Require Biopsy Confirmation?
        • Biopsy the Safest High-Yield Metastatic Site
          • Does Biopsy Confirm Metastatic Disease?
            • Stage Metastatic Sites, Burden, and Distribution
              • Is Disease Symptomatic or Organ-Threatening?
                • Deliver Urgent Site-Directed or Palliative Treatment
                  • Is Disease Limited or Oligometastatic?
                    • Complete MDT Review of Metastasis-Directed Options
                      M1 disease is primarily managed with systemic therapy, clinical trials, and symptom-directed supportive treatment. Radiotherapy is appropriate for palliation of selected symptomatic primary, nodal, or distant lesions rather than as the principal systemic treatment.
                    • Use Metastatic Systemic-Treatment Pathway
                • Is Disease Limited or Oligometastatic?
                  • Complete MDT Review of Metastasis-Directed Options
                    M1 disease is primarily managed with systemic therapy, clinical trials, and symptom-directed supportive treatment. Radiotherapy is appropriate for palliation of selected symptomatic primary, nodal, or distant lesions rather than as the principal systemic treatment.
                  • Use Metastatic Systemic-Treatment Pathway
            • Resolve Indeterminate M1 Finding With Additional Imaging and/or Alternative-Site Biopsy
        • M1 Disease Adequately Established Without Biopsy
          • Stage Metastatic Sites, Burden, and Distribution
            • Is Disease Symptomatic or Organ-Threatening?
              • Deliver Urgent Site-Directed or Palliative Treatment
                • Is Disease Limited or Oligometastatic?
                  • Complete MDT Review of Metastasis-Directed Options
                    M1 disease is primarily managed with systemic therapy, clinical trials, and symptom-directed supportive treatment. Radiotherapy is appropriate for palliation of selected symptomatic primary, nodal, or distant lesions rather than as the principal systemic treatment.
                  • Use Metastatic Systemic-Treatment Pathway
              • Is Disease Limited or Oligometastatic?
                • Complete MDT Review of Metastasis-Directed Options
                  M1 disease is primarily managed with systemic therapy, clinical trials, and symptom-directed supportive treatment. Radiotherapy is appropriate for palliation of selected symptomatic primary, nodal, or distant lesions rather than as the principal systemic treatment.
                • Use Metastatic Systemic-Treatment Pathway
      • Is Regional Metastasis Pathologically Confirmed?
        • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
        • Obtain Percutaneous Inguinal Nodal Biopsy
          • Is Nodal Biopsy Positive?
            • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
            • Does Clinical Nodal Suspicion Persist?
              • Repeat Biopsy or Perform Excisional Biopsy
                • Is Repeat Nodal Assessment Positive?
                  • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                  • Is Prophylactic Inguinal RT Planned?
                    • Do Not Use RT for Occult Nodal Staging
                      • Classify cN0 Primary Tumor Risk
                        • Start Structured Inguinal Surveillance
                        • Is DSLNB Available at an Experienced Center?
                          • Perform Dynamic Sentinel Lymph Node Biopsy
                            • Are Metastatic Nodes Detected?
                              • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                              • Start Structured Inguinal Surveillance
                          • Perform Modified ILND With Frozen Section
                            • Are Metastatic Nodes Detected?
                              • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                              • Start Structured Inguinal Surveillance
                    • Classify cN0 Primary Tumor Risk
                      • Start Structured Inguinal Surveillance
                      • Is DSLNB Available at an Experienced Center?
                        • Perform Dynamic Sentinel Lymph Node Biopsy
                          • Are Metastatic Nodes Detected?
                            • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                            • Start Structured Inguinal Surveillance
                        • Perform Modified ILND With Frozen Section
                          • Are Metastatic Nodes Detected?
                            • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                            • Start Structured Inguinal Surveillance
              • Is Prophylactic Inguinal RT Planned?
                • Do Not Use RT for Occult Nodal Staging
                  • Classify cN0 Primary Tumor Risk
                    • Start Structured Inguinal Surveillance
                    • Is DSLNB Available at an Experienced Center?
                      • Perform Dynamic Sentinel Lymph Node Biopsy
                        • Are Metastatic Nodes Detected?
                          • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                          • Start Structured Inguinal Surveillance
                      • Perform Modified ILND With Frozen Section
                        • Are Metastatic Nodes Detected?
                          • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                          • Start Structured Inguinal Surveillance
                • Classify cN0 Primary Tumor Risk
                  • Start Structured Inguinal Surveillance
                  • Is DSLNB Available at an Experienced Center?
                    • Perform Dynamic Sentinel Lymph Node Biopsy
                      • Are Metastatic Nodes Detected?
                        • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                        • Start Structured Inguinal Surveillance
                    • Perform Modified ILND With Frozen Section
                      • Are Metastatic Nodes Detected?
                        • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                        • Start Structured Inguinal Surveillance
      • Perform Bilateral Inguinal Ultrasound
        • Morphologically Abnormal Inguinal Node?
          • Obtain Percutaneous Inguinal Nodal Biopsy
            • Is Nodal Biopsy Positive?
              • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
              • Does Clinical Nodal Suspicion Persist?
                • Repeat Biopsy or Perform Excisional Biopsy
                  • Is Repeat Nodal Assessment Positive?
                    • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                    • Is Prophylactic Inguinal RT Planned?
                      • Do Not Use RT for Occult Nodal Staging
                        • Classify cN0 Primary Tumor Risk
                          • Start Structured Inguinal Surveillance
                          • Is DSLNB Available at an Experienced Center?
                            • Perform Dynamic Sentinel Lymph Node Biopsy
                              • Are Metastatic Nodes Detected?
                                • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                                • Start Structured Inguinal Surveillance
                            • Perform Modified ILND With Frozen Section
                              • Are Metastatic Nodes Detected?
                                • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                                • Start Structured Inguinal Surveillance
                      • Classify cN0 Primary Tumor Risk
                        • Start Structured Inguinal Surveillance
                        • Is DSLNB Available at an Experienced Center?
                          • Perform Dynamic Sentinel Lymph Node Biopsy
                            • Are Metastatic Nodes Detected?
                              • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                              • Start Structured Inguinal Surveillance
                          • Perform Modified ILND With Frozen Section
                            • Are Metastatic Nodes Detected?
                              • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                              • Start Structured Inguinal Surveillance
                • Is Prophylactic Inguinal RT Planned?
                  • Do Not Use RT for Occult Nodal Staging
                    • Classify cN0 Primary Tumor Risk
                      • Start Structured Inguinal Surveillance
                      • Is DSLNB Available at an Experienced Center?
                        • Perform Dynamic Sentinel Lymph Node Biopsy
                          • Are Metastatic Nodes Detected?
                            • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                            • Start Structured Inguinal Surveillance
                        • Perform Modified ILND With Frozen Section
                          • Are Metastatic Nodes Detected?
                            • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                            • Start Structured Inguinal Surveillance
                  • Classify cN0 Primary Tumor Risk
                    • Start Structured Inguinal Surveillance
                    • Is DSLNB Available at an Experienced Center?
                      • Perform Dynamic Sentinel Lymph Node Biopsy
                        • Are Metastatic Nodes Detected?
                          • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                          • Start Structured Inguinal Surveillance
                      • Perform Modified ILND With Frozen Section
                        • Are Metastatic Nodes Detected?
                          • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                          • Start Structured Inguinal Surveillance
          • Is Prophylactic Inguinal RT Planned?
            • Do Not Use RT for Occult Nodal Staging
              • Classify cN0 Primary Tumor Risk
                • Start Structured Inguinal Surveillance
                • Is DSLNB Available at an Experienced Center?
                  • Perform Dynamic Sentinel Lymph Node Biopsy
                    • Are Metastatic Nodes Detected?
                      • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                      • Start Structured Inguinal Surveillance
                  • Perform Modified ILND With Frozen Section
                    • Are Metastatic Nodes Detected?
                      • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                      • Start Structured Inguinal Surveillance
            • Classify cN0 Primary Tumor Risk
              • Start Structured Inguinal Surveillance
              • Is DSLNB Available at an Experienced Center?
                • Perform Dynamic Sentinel Lymph Node Biopsy
                  • Are Metastatic Nodes Detected?
                    • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                    • Start Structured Inguinal Surveillance
                • Perform Modified ILND With Frozen Section
                  • Are Metastatic Nodes Detected?
                    • Use Node-Positive Multimodal Pathway; Reserve RT for Indications
                    • Start Structured Inguinal Surveillance
tosprivacy